Originally published on Thu February 23, 2012 10:19 am
A woman holds an AeroShot inhalable caffeine device in Boston.
Credit Charles Krupa / AP
Since we introduced you to AeroShot, a product that delivers a blast of caffeine through an inhaler, a few months back, it seems a lot of folks — mostly around college campuses in New York and Boston — have tried the quick pick-me-up.
A key legal case challenging cuts in Medicaid pay for doctors, hospitals and pharmacists is heading back to California.
Credit Keith J. R. Binns / iStockphoto.com
The Supreme Court has officially declined to decide one of its bigger cases of the term: whether or not doctors, hospitals and other health care providers can sue a state to challenge cuts in the Medicaid health program for the poor.
A key federal panel Wednesday recommended the Food and Drug Administration approve the first new weight-loss drug in more than a decade.
At the conclusion of a day-long hearing, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 to endorse a request from Vivus to approve the drug Qnexa. The same panel gave a thumbs-down to Qnexa in 2010.
Qnexa is a combination of two generic drugs that are already on the market:
If you happen to notice sometime later this year that you're suddenly paying a lot more for orange juice, you can blame America's food safety authorities. The U.S. Food and Drug Administration, after several weeks of deliberation, has blocked imports of frozen, concentrated orange juice from Brazil, probably for the next 18 months or so, even though the agency says the juice is perfectly safe.